• bitcoinBitcoin(BTC)$61,788.00-3.19%
  • ethereumEthereum(ETH)$1,751.11-3.11%
  • tetherTether(USDT)$1.000.00%
  • binancecoinBNB(BNB)$572.03-3.00%
  • usd-coinUSDC(USDC)$1.000.01%
  • rippleXRP(XRP)$0.96-2.47%
  • solanaSolana(SOL)$72.16-3.33%
  • tronTRON(TRX)$0.307824-1.35%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.020.00%
  • HyperliquidHyperliquid(HYPE)$65.17-4.82%
  • zcashZcash(ZEC)$838.00-11.67%
  • moneroMonero(XMR)$476.93-5.23%
  • dogecoinDogecoin(DOGE)$0.057181-3.79%
  • leo-tokenLEO Token(LEO)$9.25-0.77%
  • whitebitWhiteBIT Coin(WBT)$59.91-3.17%
  • chainlinkChainlink(LINK)$8.86-3.67%
  • USDSUSDS(USDS)$1.00-0.01%
  • cardanoCardano(ADA)$0.149426-3.08%
  • Ethena USDeEthena USDe(USDE)$1.00-0.01%
  • stellarStellar(XLM)$0.133200-3.43%
  • daiDai(DAI)$1.000.00%
  • bitcoin-cashBitcoin Cash(BCH)$201.49-3.37%
  • nearNEAR Protocol(NEAR)$3.01-11.69%
  • litecoinLitecoin(LTC)$41.59-6.76%
  • CantonCanton(CC)$0.079904-3.77%
  • avalanche-2Avalanche(AVAX)$6.90-2.64%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.02-0.93%
  • uniswapUniswap(UNI)$4.81-7.75%
  • USD1USD1(USD1)$1.000.00%
  • tether-goldTether Gold(XAUT)$3,570.32-4.05%
  • suiSui(SUI)$0.70-4.60%
  • RainRain(RAIN)$0.004020-8.70%
  • Ripple USDRipple USD(RLUSD)$1.00-0.01%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • hedera-hashgraphHedera(HBAR)$0.053958-2.80%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.20%
  • BittensorBittensor(TAO)$187.20-4.82%
  • shiba-inuShiba Inu(SHIB)$0.000004-3.59%
  • crypto-com-chainCronos(CRO)$0.040979-1.71%
  • quant-networkQuant(QNT)$144.20-5.03%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.12-0.18%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • MemeCoreMemeCore(M)$0.86-2.19%
  • Falcon USDFalcon USD(USDF)$1.000.01%
  • okbOKB(OKB)$83.07-5.17%
  • United StablesUnited Stables(U)$1.000.05%
  • pax-goldPAX Gold(PAXG)$3,567.97-4.10%
  • aaveAave(AAVE)$102.76-6.64%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

‘Pharma Bro’ Martin Shkreli’s lifetime drug industry ban upheld

January 23, 2024
in Business
Reading Time: 7 mins read
A A
‘Pharma Bro’ Martin Shkreli’s lifetime drug industry ban upheld
ShareShareShareShareShare

Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday upheld his lifetime ban.

A three-judge panel of the 2nd US Circuit Court of Appeals in Manhattan said a lower court judge acted properly in imposing the ban because of Shkreli’s antitrust violations.

YOU MAY ALSO LIKE

Dole to lay off 404 workers in Central Valley plant closures

California AG Rob Bonta serves Nvidia with subpoena in wake of Jensen Huang’s Chinese spy, affairs scandals

The case had been brought by the Federal Trade Commission, joined by New York, California, Illinois, North Carolina, Ohio, Pennsylvania and Virginia.

Shkreli, 40, became notorious and gained the sobriquet “Pharma Bro” when, as chief executive of Turing Pharmaceuticals in 2015, he raised the price of the newly-acquired antiparasitic drug Daraprim overnight to $750 per tablet from $17.50.

He later served more than four years in prison following his 2017 conviction for defrauding investors in two hedge funds and scheming to defraud investors in another drugmaker.

In January 2022, US District Judge Denise Cote imposed Shkreli’s lifetime ban and ordered him to repay $64.6 million, citing his “particularly heartless and coercive” tactics in monopolizing Daraprim and keeping generic rivals off the market.


Martin Shkreli served over four years in prison following his 2017 conviction for defrauding investors. REUTERS

Daraprim is used to treat toxoplasmosis, including in AIDS patients.

The appeals court rejected Shkreli’s arguments that Cote’s injunction was overbroad, and unconstitutionally chilled his free speech by preventing him even from using social media to discuss the pharmaceutical industry.

“Given Shkreli’s pattern of past misconduct, the obvious likelihood of its recurrence, and the life-threatening nature of its results, we are persuaded that the district court’s determination as to the proper scope of the injunction was well within its discretion,” the court said.


Activists protesting high drug prices in 2015.
Activists protest Shkreli’s raising if drug prices in 2015. AP

Shkreli’s lawyers did not immediately respond to requests for comment.

The FTC did not immediately respond to a similar request.

Since his May 2022 release from prison, Shkreli has worked as a software developer and as a consultant for a law office.

The case is Federal Trade Commission et al v. Shkreli, 2nd US Circuit Court of Appeals, No. 22-728.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Dole to lay off 404 workers in Central Valley plant closures
Business

Dole to lay off 404 workers in Central Valley plant closures

November 20, 2026
California AG Rob Bonta serves Nvidia with subpoena in wake of Jensen Huang’s Chinese spy, affairs scandals
Business

California AG Rob Bonta serves Nvidia with subpoena in wake of Jensen Huang’s Chinese spy, affairs scandals

November 19, 2026
Larry Fink’s next major move could be an AI play — with deep-pocketed partners in the Middle East
Business

Larry Fink’s next major move could be an AI play — with deep-pocketed partners in the Middle East

November 19, 2026
Nvidia exec reportedly berated by Huang faces scandal as his wife is accused of chip smuggling
Business

Nvidia exec reportedly berated by Huang faces scandal as his wife is accused of chip smuggling

November 19, 2026
Next Post
Google's next Chrome update adds three new generative AI features

Google's next Chrome update adds three new generative AI features

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Affording America: The rising costs of family farming

Affording America: The rising costs of family farming

November 13, 2026
Denny’s to restore Jensen Huang plaque after San Jose diner ‘bosses’ removed it over Nvidia scandal

Denny’s to restore Jensen Huang plaque after San Jose diner ‘bosses’ removed it over Nvidia scandal

November 14, 2026
Trump holds two rallies in critical Texas battleground

Trump holds two rallies in critical Texas battleground

November 15, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!